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Abstract: Several studies have emphasized the heterogeneity of fibromyalgia patients. Furthermore,
fibromyalgia patients are considered a high-risk suicide group. The ideation-to-action framework pro-
poses a set of transdiagnostic psychological factors involved in the development of suicidal ideation.
The present study aims to explore the existence of different subgroups according to their vulnerability
to suicidal ideation through these transdiagnostic psychological variables and a set of variables
typically associated with fibromyalgia. In this cross-sectional study, 151 fibromyalgia patients were
assessed through the Revised Fibromyalgia Impact Questionnaire, Beck Depression Inventory-II,
Plutchik Suicide Risk Scale, Interpersonal Needs Questionnaire, Defeat Scale, Entrapment Scale, Psy-
chache Scale, and Beck Hopelessness Scale. A K-means cluster analysis identified two clusters, one
(45.70%) according to a low vulnerability, and a second (54.30%) with a high vulnerability to suicidal
ideation. These clusters showed statistically significant differences in suicidal ideation and suicide
risk. However, no differences were observed in most socio-demographic variables. In conclusion,
fibromyalgia patients who present a clinical condition characterized by a moderate-high degree of
physical dysfunction, overall disease impact and intensity of fibromyalgia-associated symptoms,
along with a high degree of perceived burdensomeness, thwarted belongingness, defeat, entrapment,
psychological pain and hopelessness, form a homogeneous group at high risk for suicidal ideation.
Keywords: suicidal ideation; suicide; fibromyalgia; profiles; transdiagnostic psychological factors
1. Introduction
Fibromyalgia (FM) is a multisystemic syndrome characterized by the presence of
generalized pain, tenderness, stiffness, and other associated symptoms such as fatigue,
insomnia, anxiety, depression, and somatic complaints of various kinds [1,2]. The average
global prevalence of FM is 2.4%, with notable variations by country; from 0.4% in Greece to
9.3% in Tunisia [3]. FM can affect any age and the female-to-male ratio is 8–10:1 [4], although
most are women between 40 and 60 years old [5]. In addition, fibromyalgia syndrome
is associated with a significant burden on the individual and society [6]. FM patients
have a high co-morbidity with depression, anxiety, post-traumatic stress disorder, and
obsessive-compulsive disorder [7]. Psychosocial and behavioral problems may contribute
to and modify the presentation and treatment of fibromyalgia [7].
In general, the treatment of FM is symptomatic and requires a multidisciplinary
approach combining non-pharmacological (e.g., physical exercise, psychotherapy, physical
therapy, etc.) and pharmacological treatment [8,9]. Pharmacological treatment has not
demonstrated a great improvement of all symptomatic domains, nor a large effect or
higher efficacy than other treatments [6,10]. Half of FM patients are dissatisfied with the
medication they receive [11] and only 25% of those who initiate pharmacological treatment
continue it after one year [12]. Adherence to treatment is low and a significant proportion of
patients do not receive adequate treatment [12]. Similarly, non-pharmacological treatment
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is perceived as ineffective and unsatisfactory [13,14]. There is no evidence of an increase in
overall mortality among FM patients, nor a reduction in life expectancy [15], although an
increase in suicides and accidental deaths compared to the general population is found [16].
There is evidence in the literature that groups with chronic pain, such as people with
FM, are at high risk for suicide [17,18]. Additionally, the risk of suicide is higher in people
with pain who have multiple physical and psychological symptoms [19]. Therefore, the
study of the suicidal phenomenon in FM should be addressed through a comprehensive
evaluation that includes the physical and psychological comorbidity of these patients.
In a systematic review of studies conducted primarily in the U.S. population, Tang
and Crane [20] found that the lifetime prevalence of suicidal ideation in people with
a clinical condition characterized by chronic pain (migraine, orthopedic patients with
pain for more than seven months, rheumatoid arthritis, chronic abdominal pain, and
chronic non-malignant pain) was approximately 20%, with notable differences between
the different samples (from 5% of orthopedic patients to 50% of patients with chronic
non-malignant pain). Likewise, some studies have shown a point prevalence of about 50%
in FM patients [21].
Suicidal ideation is defined as the state characterized by thoughts or desires of be-
ing dead or ending one’s life [22]. Suicidal desire involves uneasiness and suffering for
the affected person, often in silence [23]. Suicidal ideation may be a precedent to other
more serious suicidal behaviors [23] and is the third strongest predictor of death by sui-
cide [24]. Therefore, the study of factors involved in the development of suicidal ideation
in FM patients is essential to reduce psychological distress and reduce other more severe
suicidal behaviors.
Previous studies [25,26] have highlighted the need to go beyond psychiatric disorders
to predict and explain suicidal ideation and other behaviors in patients with chronic
pain [27]. A novel perspective on the conceptualization of the suicidal phenomenon
is the ideation-to-action framework [28,29]. The main characteristic of this perspective
is the understanding of the suicidal phenomenon in two differentiated processes: the
development of suicidal ideation (and the variables essentially involved in this process)
and the transition from ideation to suicidal action (and the variables primarily involved in
this transition). The three predominant ideation-to-action models are: the interpersonal
theory of suicide (IPTS; [30]), the integrated motivational-volitional model of suicide
(IMV; [31]), and the three-step theory (3ST; [32]). All three models share this distinction
(ideation vs. action) but differ in the key variables involved in each.
The first model that was developed within this theoretical perspective was the
IPTS [30]. This model postulates that the development of suicidal ideation is contingent
on the frustration of the need for relationship, which is operationalized in two variables:
perceived burdensomeness (i.e., the belief of being a burden to oneself or others) and
thwarted belongingness (i.e., the experience of feeling disconnected from valuable social
circles, such as family or friends). The central hypothesis is that suicidal desire emerges
when high levels of both variables are experienced [33]. In patients with chronic pain,
perceived burdensomeness has been significantly associated with suicidal ideation [34,35].
In addition, Fishbain et al. [34] found a greater perceived burdensomeness in patients
with chronic pain compared to patients with acute pain and a control group. Similarly,
in a sample of FM patients, Lafuente-Castro et al. [36] showed that patients with suicidal
ideation scored significantly higher in perceived burdensomeness than patients without
suicidal ideation and the control group. Likewise, FM patients scored significantly higher
in thwarted belongingness than the control group.
According to IMV [31], the key variables involved in the development of suicidal
ideation/intention are defeat and entrapment. According to the cry of pain theory hy-
pothesis [37], suicidal ideation/intention arises when people feel defeated (i.e., perceived
failed struggle and helplessness as a result of a loss or significant alteration of social status,
identity, or goals) and there is no perceived escape or rescue from such a situation (i.e.,
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entrapment). While the main assumptions of IMV have been supported empirically in
previous studies [38–41], they have not been tested in people with chronic pain [27].
Finally, the most recent ideation-to-action theory is 3ST [32]. According to this theory,
pain and hopelessness are the most relevant variables involved in the development of
suicidal ideation. The 3ST positions psychological pain (i.e., aversive and unbearable
internal experience, composed of a combination of feelings such as shame, humiliation,
loneliness, fear, or distress; [42]) as the type of pain most frequently involved in the
emergence of suicidal ideation. Although experiencing chronic physical pain is clearly
associated with increased suicidal risk, psychological pain has been shown to be a stronger
predictor of suicide [26]. In addition, previous findings suggest that there is substantial
overlap between the neural correlates of physical pain and psychological pain [43].
The multifaceted expression of FM, with marked variability in presentation and
severity of symptoms, suggests that FM patients are a heterogeneous group [44,45]. Con-
sequently, the variability of FM-associated symptoms has contributed to the more costly
and time-consuming process of obtaining a diagnosis and, consequently, the difficulty of
establishing appropriate treatment [46]. Some authors have found the existence of different
FM subgroups based on physical and psychological/cognitive symptoms associated with
fibromyalgia syndrome (see Perez-Aranda et al. [47], for a review). Studies such as that of
Luciano et al. [48] identified three subgroups of FM patients: one subgroup with scores con-
sistent with low-moderate severity on all physical and psychological variables (functional
profile), a second subgroup with moderate-high scores on all variables and consistent with
a dysfunctional profile, and a third subgroup similar to the dysfunctional profile but with
higher scores on psychological variables such as depression, anxiety, and catastrophism.
However, the same number of profiles is not always found. Studies by Vincent et al. [49]
and Follick et al. [50] have identified four subgroups of FM patients: two extreme sub-
groups with high vs. low scores on all variables and two subgroups with moderate physical
symptoms distinguishable from each other by degree of psychological condition (high vs.
low). Likewise, studies based on more specific aspects, such as the psychopathological
dimensions of personality, found the existence of two subgroups differentiated mainly by
the degree (low vs. high) of negative emotionality/neuroticism, aggressiveness, restraint
(i.e., the degree to which behavior is limited by consideration of future consequences)
and introversion [51]. In this line, Torres et al. [52] found two subgroups of FM patients:
one with a maladaptive personality profile (i.e., high predisposition to social distress, low
positive affectivity, tendency to inhibitory behavior, less open to experience, low coopera-
tive behavior, less proactive and with a tendency to maladaptive strategies for managing
social conflicts) and another with scores in line with an adapted personality. Despite the
differences in the number of subgroups and variables used, previous studies have found
variability in the presence and intensity of symptoms associated with fibromyalgia syn-
drome. The heterogeneity presented by FM patients requires the establishment of profiles
so that they can benefit from specific treatment (psychological and/or pharmacological)
according to their characteristics. As we have seen, the prevalence and severity of suicidal
ideation in this group is remarkable [19]. However, studies exploring the variables related
to suicidal behavior in FM patients are scarce [53].
The present study aims to explore the existence of different subgroups of FM patients
according to their vulnerability to suicidal ideation. To this end, key variables included
in the ideation-to-action theories and that are essentially involved in the development
of suicidal ideation (i.e., perceived burdensomeness, thwarted belongingness, defeat,
entrapment, psychological pain, and hopelessness) will be taken into account, as well
as variables essentially related to the fibromyalgia syndrome, such as physical function,
overall impact of FM, intensity of physical pain and symptoms associated with FM and
severity of depressive symptoms. This will allow us to establish profiles that cover the
wide spectrum of physical and psychological symptoms of these patients, as well as to
evaluate whether the degree of physical dysfunction or severity is consistent with the
presence of high values in the variables involved in suicidal ideation and, therefore, could
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be part of a potential profile of patients vulnerable to suffering from it. The results of this
work could orient psychological therapy towards new therapeutic targets that have not
been explored among FM patients (e.g., perception of defeat and entrapment), as well
as emphasize the relevance of a holistic approach (physical and psychological) of FM
patients in the screening and treatment of suicidal ideation. According to the ideation-to-
action framework, preventing suicidal ideation is reducing distress and preventing suicidal
behavior, since the development of suicidal ideation is the first and most common step on
the pathway to more serious suicidal behavior.
2. Materials and Methods
2.1. Participants
The selection of participants was carried out by incidental sampling. The sample
consisted of a total of 151 FM patients residing in Spain (Mage = 49.82, SDage = 10.10,
Range = 20–72 years old; 88.8% women) who completed an online questionnaire. The
inclusion criteria were: (1) to be older than 18 years old, and (2) self-report being diagnosed
with FM according to the criteria of the American College of Rheumatology 1990 [1]. No
exclusion criteria were established. Sociodemographic characteristics can be seen in Table 1.










(Cluster 1 vs. Cluster 2)




SD = 9.13 0.634 *
Sex
0.144 **Woman 134 (91.2%) 64 (92.8%) 70 (89.7%)
Man 13 (8.8%) 5 (7.2%) 8 (10.3%)
Completed education level
0.278 **
No studies 3 (2%) 1 (1.4%) 2 (2.6%)
Primary education 20 (13.6%) 8 (11.6%) 12 (15.4%)
Secondary education 80 (54.4%) 34 (49.3%) 46 (59.0%)
Higher education 44 (29.9%) 26 (37.7%) 18 (23.1%)
Work activity
0.005 **
Unemployed 29 (19.7%) 9 (13.0%) 20 (25.6%)
Student 4 (2.7%) 2 (2.9%) 2 (2.6%)
Homemaker 20 (13.6%) 8 (11.6%) 12 (15.4%)
Employee 55 (37.4%) 30 (43.5%) 25 (32.1%)
Sick leaved 14 (9.5%) 2 (2.9%) 12 (15.4%)
Retired/Pensioner/Rentist 25 (17.0%) 18 (26.1%) 7 (9.0%)
Civil status
0.291 **
Single 28 (20.1%) 13 (19.4%) 15 (20.8%)
Stable partner 15 (10.8%) 6 (9.0%) 9 (12.5%)
Married 76 (54.7%) 42 (62.7%) 34 (47.2%)
Divorced 18 (12.9%) 5 (7.5%) 13 (18.1%)
Widowed 2 (1.4%) 1 (1.5%) 1 (1.4%)
Religion
0.192 **
Catholic 76 (53.9%) 36 (52.9%) 40 (54.8%)
Orthodox 2 (1.4%) 2 (2.9%) -
Protestant 2 (1.4%) 2 (2.9%) -
Agnostic 13 (9.2%) 8 (11.8%) 5 (6.8%)
Atheist 24 (17.0%) 8 (11.8%) 16 (21.9%)
Indifferent 24 (17.0%) 12 (17.6%) 12 (16.4%)
Note: SD = standard deviation; * Student’s t-test, ** Chi-squared Test.
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2.2. Instruments
Fibromyalgia Impact Questionnaire Revised (FIQ-R; [54]) was adapted to Spanish [55].
A self-administered questionnaire measures the overall impact of FM on patients’ quality of
life. It consists of 21 items with visual analog scale (VAS) response options with a response
range from 0 to 10. It is composed of three dimensions: (a) degree of difficulty of the
physical activity (scores are obtained by adding the first nine items divided by 3, ranging
from 0 to 30 points); (b) overall impact of FM (scores are obtained by adding items 10
and 11, ranging from 0 to 20 points); (c) intensity of FM-associated symptoms (scores are
obtained by adding the last ten items divided by 2, ranging from 0 to 50 points). For this
study, each of the dimensions was treated independently in order to assess their specific
contribution (physical or psychological) to the classification of participants. In addition, the
FM symptoms dimension does not include item 12 (pain), as it was treated as an indicator
of physical pain intensity. In this paper, estimates of the reliability of the scores for each
dimension using the Cronbach alpha coefficient were 0.94 (physical function), 0.88 (overall
impact), and 0.87 (associated symptoms).
Beck Depression Inventory, version II (BDI-II; [56]) adapted to Spanish [57]. Self-
administered 21-item scale with a multiple choice (between 0 and 3 points) to measure the
severity of depressive symptoms. The BDI-II was used for this study by subtracting the
score of item 9 (suicidal ideation), which was used as an indicator of suicidal ideation. The
estimate of the reliability of the BDI-II scores was 0.90.
Plutchik Suicide Risk Scale (PSRS; [58]) adapted to Spanish [59]. Self-applied scale
with 15 items that measures aspects related to suicidal behaviors. The response format is
true/false. The internal consistency of the scale scores through Cronbach’s alpha coefficient
was 0.75.
Interpersonal Needs Questionnaire (INQ-10; [60]) adapted to Spanish [61]. This self-
administered 10-item questionnaire evaluates perceived burdensomeness (first six items)
and thwarted belongingness (last four items). The response options are of the seven-point
Likert type, ranging from 1 (not entirely true for me) to 7 (entirely true for me). The
reliability estimate of the INQ-subscale scores through Cronbach’s alpha coefficient were
0.93 (perceived burdensomeness) and 0.84 (thwarted belongingness).
Defeat Scale (DS; [62]) adapted to Spanish [63]. Self-administered 16-item scale that
measures how often participants have felt defeated. The response options are 5-point Likert
type, from 0 (never) to 4 (always). In our sample, the reliability estimate of the defeat scale
scores through Cronbach’s alpha coefficient was 0.95.
Entrapment scale (ES; [62]) adapted to Spanish [63]. This self-administered scale of
16 items evaluates the perception of entrapment. The response options are 5-point Likert
type, from 0 (not quite like me) to 4 (extremely like me). The reliability estimate through
Cronbach’s alpha coefficient was 0.96.
Psychache Scale (PS; [64]) adapted to Spanish [65]. Self-administered 13-item scale
that assesses the degree of psychological pain. The response options to the first nine items
range from 1 (never) to 5 (always). The response options to the last four items range from 1
(strongly disagree) to 5 (strongly agree). The estimate of the reliability of the scores through
Cronbach’s alpha coefficient was 0.93.
Beck Hopelessness Scale (BHS; [66]) adapted to Spanish [67]. Self-administered 20-
item scale that measures negative expectations about the future, well-being, and ability to
cope with difficulties. The response format is true/false. The estimation of the reliability of
the scores through Cronbach’s alpha coefficient was 0.91.
2.3. Procedure
The present study has a cross-sectional design. The managers of a group of FM
patient associations located in different parts of Spain were contacted and they promoted
and distributed among their members a questionnaire in line with the scales and socio-
demographic questions of the study (http://encuestas.ual.es/limesurvey/index.php/5396
41?lang=es). Participation was anonymous and voluntary. All the participants gave their
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informed consent. They were provided with a contact address to answer any questions
about their participation in the study. This study was approved by the Bioethics Committee
on Human Research at University of Almería, Spain (Ref: UALBIO2018/018).
2.4. Data Analysis
A total of 185 participants began to fill out the questionnaire, which was completed
in full by 147 participants. In addition, four participants completed all the scales, but
not the socio-demographic data. Therefore, they were considered for analysis, making
a total sample of 151 participants in this study. Eleven variables were used to form
the subgroups. On the one hand, the physical and psychological variables specifically
associated to the fibromyalgia syndrome: difficulty of physical activity (total score of
the physical function dimension of the FIQ-R), overall impact of FM (total score of this
dimension of the FIQ-R), intensity of FM associated symptoms (adjusted total score of this
dimension of the FIQ-R, excluding item 12: physical pain), intensity of physical pain (score
of item 12 of the FIQ-R; to specifically assess the contribution of the cardinal symptom of the
fibromyalgia syndrome to cluster formation) and severity of depressive symptomatology
(BDI-II adjusted without item 9: suicidal ideation). And, on the other hand, the variables
involved essentially in the development of suicidal ideation of the IPTS (total score of each
of the INQ subscales, perceived burdensomeness and thwarted belongingness), of the IMV
(total score of the defeat scale and the entrapment scale) and of the 3ST (total score of the
Psychache scale and the hopelessness scale). Prior to the cluster analysis, the scores of all
variables were standardized.
Due to the exploratory nature of the study, a hierarchical cluster analysis was first
performed in which a dendrogram was obtained (Figure 1). This dendrogram is a graphic
representation that summarizes the process of grouping the cases and provides guidance
on how many clusters should be formed. Later, in order to obtain the profiles among FM
patients, a K-means cluster analysis was performed, in which two clusters were specified
according to the results shown by the dendrogram. The method selected was iteration
and classification, a procedure that estimates the centroids iteratively and classifies the
participants according to the estimated centroids. The iteration process was stopped
when seven iterations were reached. Euclidean distance was used to measure the distance
between cases. The result showed an ANOVA to check the relevance and separation of the
variables between the clusters.
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Figure 1. Dendrogram. Figure 1. endrogra .
Also, as a cross validity procedure, three additional K-means cluster analyses were
performed with a random case selection of 25%, 50%, and 75% of the total sample to
compare the degree of stability between the different solutions. Likewise, to obtain validity
evidence on the meaning of the profiles, we compared the suicidal ideation (item 9 of the
BDI-II) and the suicidal risk (total score of the Plutchik Suicide Risk Scale) of both clusters
through the U-Mann–Whitney test (suicidal ideation) and the Student t-test (suicidal risk).
Finally, the independence of the sociodemographic characteristics of the participants was
analyzed according to their belonging to each cluster through the Chi-squared test. All
analyses were performed with IBM SPSS Statistics for Windows, Version 26.0. Armonk,
NY, USA: IBM Corp.
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3. Results
Since the dendrogram showed a clear solution of two clusters, a K-mean cluster analy-
sis was executed requesting two clusters. The ANOVA (Table 2) shows that all variables
contribute to form two distinguishable clusters (i.e., they show statistically significant
differences). Likewise, the cross-validation process through the results obtained with 25%,
50% and 75% of the cases confirms the consistency of the final solution of two clusters.
Table 2. Mean and standard deviation, centroids, and ANOVA for the solution of two clusters.
Variables
Cluster 1 (Low Vulnerability) Cluster 2 (High Vulnerability)
F p-Value




(FIQ-R) −0.48 15.38 (7.08) 0.42 21.69 (5.39) 38.526 <0.001
Overall FM impact (FIQ-R) −0.64 9.54 (4.88) 0.56 15.80 (3.48) 84.251 <0.001
Intensity of associated symptoms
(FIQ-R) −0.65 22.30 (8.75) 0.55 33.54 (6.24) 84.291 <0.001
Physical pain (FIQ-R) −0.64 5.71 (2.38) 0.56 8.60 (1.46) 83.429 <0.001
Severity depressive
symptomatology (BDI-II) −0.75 19.74 (6.91) 0.64 34.89 (8.67) 137.259 <0.001
Perceived burdensomeness (INQ) −0.62 10.52 (4.81) 0.52 22.33 (10.79) 70.676 <0.001
Thwarted belongingness (INQ) −0.22 13.80 (6.53) 0.19 16.49 (6.19) 6.730 0.010
Defeat (DS) −0.82 21.13 (10.12) 0.69 42.77 (9.17) 189.687 <0.001
Entrapment (ES) −0.80 18.87 (11.07) 0.67 42.46 (11.00) 171.460 <0.001
Psychological Pain (PS) −0.79 32.94 (9.12) 0.65 49.80 (7.27) 159.770 <0.001
Hopelessness (BHS) −0.74 5.59 (4.32) 0.61 13.55 (4.46) 122.793 <0.001
Note: FIQ-R = Fibromyalgia Impact Questionnaire Revised; BDI-II = Beck Depression Inventory, version II; INQ = Interpersonal Needs
Questionnaire; DS = Defeat scale; ES = Entrapment scale; PS = Psychache scale; BHS = Beck Hopelessness scale.
Cluster 1 (69 participants, 45.70%) is characterized by moderate values in the dimen-
sions of FIQ-R (i.e., physical function difficulty, overall impact and intensity of associated
symptoms) and in the item of physical pain intensity, mild-moderate values in the severity
of depressive symptomatology, low values of perceived burdensomeness and thwarted
belongingness, low values of perception of defeat and entrapment, moderate values of
psychological pain and low hopelessness (Table 2). This finding is congruent with a pro-
file of low vulnerability to suicidal ideation. Cluster 2 (82 participants, 54.30%) presents
moderate-high values in the three dimensions of FIQ-R and high intensity of physical
pain, values of severe depressive symptoms, moderate values of perception of perceived
burdensomeness and thwarted belongingness, as well as high values in perception of
defeat, entrapment, psychological pain and hopelessness (Table 2). It could be argued that
cluster 2 adjusts to a profile of high vulnerability to suicidal ideation. See Figure 2 for a
graphical interpretation of the profiles.
In order to obtain validity evidence on the meaning of the profiles, scores for suicidal
ideation and risk were compared between both profiles. There are statistically significant
differences (U = 4282.500; p < 0.001) in suicidal ideation between low profile (average range
= 54.93) and high profile (average range = 93.73), with participants from the latter being the
most vulnerable to suicidal ideation and therefore having higher values of suicidal ideation.
In addition, using item 15 of Plutchik Suicide Risk Scale “Have you ever tried to take your
own life?” in the low profile, 13% had tried to end their own life compared to 34.1% in the
high profile who had done so (χ2 = 9.020; p = 0.003). Similarly, when comparing suicide
risk, statistically significant differences are observed (t = −9.432; p < 0.001) between low
profile (M = 6.01; SD = 2.62) and high profile (M = 9.93; SD = 2.47). Therefore, as with
suicidal ideation, participants in high profile (high vulnerability to suicidal ideation) obtain
higher values in suicidal risk.
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Figure 2. Profiles of suicidal ideation in patients with fibromyalgia. Note: On the left side of the dividing line are the
variables specifically associated with fibromyalgia syndrome. On the right side are the variables essentially involved in
the development of suicidal ideation; 1 = Physical function difficulty, 2 = Overall FM impact, 3 = Intensity of associated
symptoms, 4 = Physical pain, 5 = Severity depressive symptomatology, 6 = Perceived burdensomeness, 7 = Thwarted
belongingness, 8 = Defeat, 9 = Entrapment, 10 = Psychological pain, 11 = Hopelessness.
Regarding the differences between profiles in the sociodemographic variables (Table 1),
no statistically significant discrepancies are observed between the participants of both clus-
ters in the frequencies of sex (χ2 = 3.870; p = 0.144), educational level completed (χ2 = 3.851;
p = 0.278), marital status (χ2 = 4.967; p = 0.291) and religion (χ2 = 7.402; p = 0.192). How-
ever, work activity does show statistically significant dependence between both subgroups
(χ2 = 16.922; p = 0.005), with a higher proportion of employees in low profile (43.5%) com-
pared to high profile (32.1%), as well as a higher proportion of retirees/pensioners/rentiers
in low profile than in high profile (26.1% vs. 9.0%). In contrast, high profile has higher
frequencies of unemployed (25.6% vs. 13.0%) and permanent disability pensioners (15.4%
vs. 2.9%) than low profile.
4. Discussi
The heterogeneous presence and severity of symptoms among FM patients limits
understanding of fibromyalgia and makes it difficult to choose appropriate treatment [68].
Despite the high prevalence of suicidal ideation in these patients [21,53], as well as the
numerous studies that have explored homogenous groups through the physical and psy-
chological factors associated with the fibromyalgia syndrome [47], neither has sought to
delineate subgroups of FM patients consistent with their vulnerability to suicidal ideation.
Likewise, the study of suicide in FM has been based primarily on psychopathological
comorbidity (e.g., depression), an approach that has proven unsuccessful in predicting
suicide and has deprived it of its own entity [24].
The present study aimed to explore the existence of homogeneous subgroups of
FM patients according t their vulnerability to suicidal ideation. The main novelty is
the use of psychological variables of transdiagnostic relevance (i.e., involved in a high
range of psychological disorders) and considered as key elements in the development
of suicidal ideatio of the thr e predo inant theories (i.e., IPTS, IMV, and 3ST) of the
ideation-to ction-fra ework. A cl ster analysis was carri d out, consisting of these
psyc ological variables (i.e., perceived burdensomeness, thwarted belongingness, defeat,
entrapment, psychological pain, and hopelessness) together with other variables associated
with fibromyalgia syndrome (i.e., difficulty of physical function, overall impact of FM,
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intensity of associated symptoms, intensity of physical pain, and severity of depressive
symptoms). Our findings show that, as expected, these variables adequately identify and
discriminate fibromyalgia patients who may be at risk of suffering from suicidal ideation,
reducing the variability to two groups (high risk/low risk), despite the heterogeneity
of these patients. Additionally, the variables of the theories behave in a similar and
concomitant way, showing a high relationship among them and their association with the
intensity of the typical symptoms of fibromyalgia (e.g., pain), physical functioning, and
impact. In short, this is an exploratory study that positions a set of variables to be examined
among fibromyalgia patients and a claim for exploring the theoretical assumptions of these
theories to clarify the high prevalence of suicidal ideation in fibromyalgia and to optimize
screening and psychological management.
The result showed a solution of two clusters (or profiles) of FM patients. A first profile
characterized by patients with low-moderate values in all the variables implemented in
the analysis, affected to a lesser extent by the fibromyalgia syndrome, physically and
psychologically, and with low values in the psychological variables involved in suicidal
ideation. Therefore, this is a group of participants that is predictably less vulnerable to
suffering suicidal ideation. It should be noted that this subgroup represented 45% of the
sample, so that more than half of the FM patients (cluster 2) obtained scores reflecting
more severe physical and psychological symptoms and scores on the variables related to
suicidal ideation comparable to a high risk of suffering from suicidal ideation. Although
this proportion does not show the specific prevalence of suicidal ideation in these patients
(48% in the study by Calandre et al. [21], or 32.5% in the study by Triñanes et al. [53]), it
denotes a marked vulnerability that makes screening and follow-up of suicidal ideation
and other behaviors in FM patients in the clinical setting indispensable.
In relation to the profile of high vulnerability to suicidal ideation, according to Ca-
lati et al. [19], patients with chronic pain who are at high suicidal risk tend to present a
highly comorbid and more exacerbated clinical condition (physical and psychological), so
a subgroup with higher values in the variables associated with fibromyalgia syndrome and
in line with higher values in the variables involved in suicidal ideation was expected. This
finding is consistent with the result of Triñanes et al. [53] about the existence of a positive
and statistically significant association between the impact of FM on daily activities and the
presence of suicidal ideation. Similarly, Calandre et al. [69] found a positive and statistically
significant association between the FIQ score and suicidal risk.
Regarding the variables involved in suicidal ideation, previous studies have shown
that people with chronic pain are perceived to be more of a burden compared to people
with acute pain and the control groups [34]. Similarly, Wilson et al. [35] found a positive
and statistically significant association between perceived burdensomeness and suicidal
ideation. With a sample of FM patients, a study by Lafuente-Castro et al. [36] showed a
higher score for perceived burdensomeness and thwarted belongingness in FM and suicidal
ideation patients compared to non-suicidal ideation patients and controls. However, in
our work, despite statistically significant differences in thwarted belongingness between
the two profiles, the size of this difference is the smallest. This result is in line with the
growing empirical evidence that perceived burdensomeness is more related to suicidal
ideation than thwarted belongingness [70,71].
To our knowledge, the perception of defeat and entrapment has not yet been ex-
plored in chronic pain patients. However, there are studies [72,73] that have evaluated
a construct similar to defeat in a long-term, intensely painful population: mental defeat
(i.e., a psychological state characterized by a loss of autonomy, individual agency, and
human integrity; [74]). Tang et al. [74] found higher levels of mental defeat in patients
with chronic pain compared to those with acute pain and those without pain. A positive,
moderate, and statistically significant association has also been found between mental
defeat and the worst suicide attempt [73]. The conceptual and methodological overlap
between perception of defeat and mental defeat [27], together with the high perception of
defeat presented by FM patients in the profile of high vulnerability to suicidal ideation,
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suggests a similar functioning of both constructs in people with chronic pain. Given that
IMV [31] is one of the most prominent models in the field of suicide, the study of key
variables and their association with the characteristics of the chronic pain population may
help to explain suicidal ideation in these patients. A meta-analysis by Ducasse et al. [75]
found that the relationships between psychological pain and ideation and other suicidal
behaviors are significant even in controlling depression. Similarly, patients with suicidal
ideation also scored higher in psychological pain compared to patients without suicidal
ideation. A systematic review by Verrocchio et al. [76] states that psychological pain may
be the most significant predictor of suicidal ideation. However, to our knowledge, there is
no research that has evaluated this variable in FM patients. In our study, participants in
the high vulnerability to suicidal ideation cluster had high scores for psychological pain,
which may be further evidence of the severity of their suicidal ideation, or their potential
vulnerability to it. These patients also show high scores for hopelessness. Interestingly,
despite studies that position hopelessness as a strong predictor of suicidal ideation [69], the
scientific literature on fibromyalgia syndrome has not delved into the role of this variable
in suicidal ideation and behavior in FM patients.
Finally, we found no statistically significant differences in the sociodemographic
variables between patients in both subgroups, except for work activity. Our findings are
consistent with those of Smith et al. [77]: sociodemographic variables are less associated
with ideation and other suicidal behaviors in patients with chronic pain. However, FM
patients were 1.9 times more likely to be absent from work due to their illness than their
colleagues [78]. In the present study, the profile of high vulnerability to suicidal ideation
consisted of a higher proportion of FM patients who were unemployed and permanently
disabled. Since these patients are the most affected by their physical and psychological
symptoms, it is understandable that they are not in a suitable condition to work. Similarly,
unemployed or permanently disabled status may be a stressor that influences the impact
of the disease [53].
This study is not exempt from limitations. Suicidal ideation was evaluated with only
one indicator (item 9 of the BDI-II). However, despite the limitations related to the capability
of a single item to capture the complexity of the construct, this item has been used frequently
in the literature and it has an outstanding reputation based on the concurrent validity
with the Beck Scale for Suicidal Ideation [79]. Another limitation is that the sample of FM
patients was recruited from associations of fibromyalgia patients located throughout Spain,
which could lead to coverage bias. Therefore, we urge caution in generalizing our findings
to all FM patients. Finally, the cross-sectional design of the research makes it impossible
to detect possible temporal fluctuations and the influence of context, which could have
an impact on all the variables analyzed. Longitudinal studies would provide information
regarding this temporal fluctuation and its possible impact on the development of suicidal
ideation in FM patients. Similarly, future studies should evaluate the contribution of other
variables (e.g., attachment styles) that have been shown to be related to ideation and
suicidal behavior in high-risk suicidal samples and fibromyalgia patients [80–83], as well
as explore the relationship of these variables and the key elements of ideation-to-action
theories.
5. Conclusions
In conclusion, FM patients who present a clinical condition characterized by a mod-
erate to high degree of physical dysfunction, overall disease impact and intensity of
FM-associated symptoms (including high severity of depressive symptoms), along with a
high degree of perceived burdensomeness, thwarted belongingness, defeat, entrapment,
psychological pain, and hopelessness, form a homogeneous group at high risk for suicidal
ideation. According to the ideation-to-action framework, preventing suicidal ideation is
not only about preventing the suffering and distress that it causes, but also limiting the
transition to suicidal action [23,84]. Therefore, in the clinical setting, assessing the variables
involved in the development of suicidal ideation could improve the screening and manage-
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ment of patients with fibromyalgia. Being able to discern between those patients who are
at risk of suffering from suicidal ideation and to orient psychological intervention to the
concrete variables, as well as to evaluate the effectiveness of psychological therapy with
pre-post measures. Likewise, we believe it is relevant that in the out-of-hospital context
(e.g., associations of patients with fibromyalgia), the variables involved in suicidal ideation
in patients with fibromyalgia should be evaluated in order to interfere in the development
as soon as possible, since only a third of the people who die by suicide had attended mental
health services in the year prior to the suicide [85]. Similarly, in the research field, ideation-
to-action theories (i.e., IPTS, IMV, and 3ST) reconceptualize the suicidal phenomenon and
propose a set of transdiagnostic psychological variables that could clarify the relationship
between chronic pain and suicidal ideation and other suicidal behaviors.
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